Catalyst Wire Dossier Catalyst Wire Dossier

Grass pollen subcutaneous immunotherapy

· ALK-Abelló A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Grass pollen subcutaneous immunotherapy, covering 2013-02-08 to 2013-02-08. Get the full timeline:

Most recent: Clinical Trial Update: Study on Pharmacodynamic Parameter and Tolerability With Subcutaneous Immunotherapy in Grass Pollen Allergic Patients [Phase 2]

See pricing